An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Acacia Research Corporation (ACTG) to report Q4 and full-year 2023 financial results on March 14, 2024. Conference call scheduled for further discussion.
Positive
None.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Acacia Research Corporation (NASDAQ: ACTG) announced today it will release its fourth quarter and full-year 2023 financial results after the market closes on Thursday, March 14, 2024.
The Company will host a conference call on the same day to discuss these results at 4:30 p.m. ET/ 1:30 p.m. PT.
To access the live call, please dial 888-506-0062 (U.S. and Canada) or 973-528-0011 (international) and if requested, reference conference ID 248690. The conference call will also be simultaneously webcasted at https://www.webcaster4.com/Webcast/Page/2371/50034 and on the investor relations section of the Company’s website at http://www.acaciaresearch.com under Events & Presentations. Following the conclusion of the live call, a replay of the webcast will be available on the Company's website for at least 30 days.
About Acacia Research
Acacia is a publicly traded (Nasdaq: ACTG) company that is focused on acquiring and operating attractive businesses across the industrial, healthcare, energy, and mature technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management. Additional information about Acacia and its subsidiaries is available at www.acaciaresearch.com.
Acacia Research Investor Contact:
FNK IR
Rob Fink, 646-809-4048
actg@fnkir.com
Source: Acacia Research Corporation
FAQ
When will Acacia Research Corporation release its Q4 and full-year 2023 financial results?
Acacia Research Corporation (ACTG) will release its fourth quarter and full-year 2023 financial results after the market closes on Thursday, March 14, 2024.
What time is the conference call to discuss the financial results scheduled?
The conference call to discuss the financial results is scheduled for 4:30 p.m. ET/ 1:30 p.m. PT on the same day.
How can I access the live conference call?
To access the live call, please dial 888-506-0062 (U.S. and Canada) or 973-528-0011 (international) and if requested, reference conference ID 248690.
Where can I find the webcast of the conference call?
The conference call will be simultaneously webcasted at https://www.webcaster4.com/Webcast/Page/2371/50034 and on the investor relations section of the Company’s website at http://www.acaciaresearch.com under Events & Presentations.
How long will the webcast replay be available?
A replay of the webcast will be available on the Company's website for at least 30 days after the live call.
acacia research corporation (nasdaq: actg) is the industry leader in patent licensing. by partnering with patent owners, acacia applies its deep legal and technology expertise to patent assets to unlock financial value. an intermediary in the patent market, acacia facilitates efficiency and delivers monetary rewards to the patent owner. with this strategy, acacia has generated over $1,200,000,000 revenue to date, and has returned more than $705,000,000 to our patent partners.
